SCHEMBL30845489

SCHEMBL30845489

COC(=O)c1cc(-c2cc(C3CC3)no2)c(C)cn1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAP3K5 Q99683 4/20 0.51
PIK3CD O00329 1/20 0.42
PIK3CB P42338 1/20 0.42
PIK3CG P48736 1/20 0.42
TP53 P04637 1/20 0.37
MAPT P10636 1/20 0.37
SLC6A3 Q01959 1/20 0.36
IRAK4 Q9NWZ3 1/20 0.36
MAPK1 P28482 2/20 0.36
NOTUM Q6P988 1/20 0.36
LMNA P02545 1/20 0.35
POLB P06746 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
RARG P13631 1/20 0.35
RARA P10276 1/20 0.34
RXRA P19793 1/20 0.34
RXRG P48443 1/20 0.34
LCK P06239 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21530453 1.00 MAP3K5 (0.51) MAP3K5PIK3CDPIK3CBPIK3CGTP53
SCHEMBL21530435 0.82 MAP3K5 (0.50) MAP3K5LMNAPOLBSMN1; SMN2NPC1
SCHEMBL30845493 0.82 MAP3K5 (0.50) MAP3K5LMNAPOLBSMN1; SMN2NPC1
SCHEMBL23365573 0.80 MAP3K5 (0.39) MAP3K5PIK3CDPIK3CBPIK3CGLMNA
SCHEMBL21530442 0.76 MAP3K5 (0.43) MAP3K5PIK3CDPIK3CBPIK3CGTP53
SCHEMBL30845495 0.76 MAP3K5 (0.43) MAP3K5PIK3CDPIK3CBPIK3CGTP53
SCHEMBL25409472 0.70 PSMB8 (0.44) MAPTSLC6A3LMNAPOLBSMN1; SMN2
SCHEMBL24296676 0.70 MAP3K5 (0.45) MAP3K5PIK3CDPIK3CBPIK3CGMAPT
SCHEMBL18825226 0.69 MAPK1 (0.53) MAPTMAPK1LMNALCK
SCHEMBL24724195 0.69 MAPK1 (0.46) MAPK1LMNAPOLBLCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112312905-B Tetrazole-containing inhibitors of apoptosis signal-regulating kinase 1 and methods of use thereof 英安塔制药有限公司 2024-03-15 CN disclosed